PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) Debt-to-Equity: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity?

PT Brigit Biofarmaka Teknologi Tbk ISX:OBAT -0.82% Debt-to-Equity is 0.00 as of . 20. The stock has 1 warning sign investors should review. Among 1,748 Consumer Packaged Goods companies, PT Brigit Biofarmaka Teknologi Tbk ranks worse than 57208.18% on this metric.

PT Brigit Biofarmaka Teknologi Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. PT Brigit Biofarmaka Teknologi Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. PT Brigit Biofarmaka Teknologi Tbk's Total Stockholders Equity for the quarter that ended in . 20 was Rp0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity or its related term are showing as below:

ISX:OBAT's Debt-to-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.42
* Ranked among companies with meaningful Debt-to-Equity only.

PT Brigit Biofarmaka Teknologi Tbk  (ISX:OBAT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity Related Terms

PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity Chart

PT Brigit Biofarmaka Teknologi Tbk Annual Data
Trend
Debt-to-Equity

PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Debt-to-Equity

ISX:OBAT vs KHC, GIS: Debt-to-Equity Comparison

For the Packaged Foods subindustry, PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity falls into.


PT Brigit Biofarmaka Teknologi Tbk Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

PT Brigit Biofarmaka Teknologi Tbk's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) / N/A
=N/A

PT Brigit Biofarmaka Teknologi Tbk's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Debt-to-Equity of 0.00 as of . 20. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. According to the industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1748 companies in the Consumer Packaged Goods industry.
Is PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity too high?
PT Brigit Biofarmaka Teknologi Tbk's current Debt-to-Equity is 0.00. Based on the distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1748 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PT Brigit Biofarmaka Teknologi Tbk's Debt-to-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1748 companies for Debt-to-Equity. This places PT Brigit Biofarmaka Teknologi Tbk in the lower half of its industry. The industry median Debt-to-Equity is 0.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.42, based on 1,748 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Brigit Biofarmaka Teknologi Tbk's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Debt-to-Equity is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Brigit Biofarmaka Teknologi Tbk Business Description

Address Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan, Tawangsari, Kab. Sukoharjo, Jawa Tengah, IDN, 57561
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.